Trial Profile
Phase 4 clinical trial to examine the role of rosuvastatin and exercise treatment in modulating inflammatory response in hypercholesterolemic subjects.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Pharmacodynamics
- 07 Oct 2006 New trial record.